Home/Smart Money/Patient Square Capital LP
§ 13F · FUND PROFILE

Patient Square Capital LP.

AUM · $646M (13F)Positions · 23Turnover · n/a · Q2Filed · Aug 12, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$104M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 12, 2026
#TickerNameShares$ value% portΔ Q2
1ROIVROIVANT SCIENCES LTD8.02M$284M44.0%−2%
2RVMDREVOLUTION MEDICINES INC276K$52M8.0%NEW
3MIRMMIRUM PHARMACEUTICALS INC261K$30M4.7%+13%
4ABVXABIVAX SA207K$28M4.3%+70%
5ONCBEONE MEDICINES LTD90K$26M4.0%+12%
6PHVSPHARVARIS N V671K$23M3.6%+36%
7ARGXARGENX SE23K$21M3.3%−37%
8UTHRUNITED THERAPEUTICS CORP DEL37K$20M3.1%NEW
9BLTEBELITE BIO INC110K$17M2.6%−6%
10COGTCOGENT BIOSCIENCES INC425K$16M2.5%−29%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE PATIENT SIGNAL

AC read

Patient Square Capital LP is a Other fund managing $646 million in assets. The fund runs a focused portfolio of just 23 positions.

Read the full dossier →